DDX17 and fatty liver disease: Overall, our study reveals the role of the DDX17/Cyp2c29/ 14, 15‐EET pathway in lipid metabolism and subsequent inflammatory response and provides promising targets for the treatment of hepatic steatosis, inflammation and fibrosis.